Trait Information | |
Identifier | MONDO_0002406 |
Description | An inflammatory process affecting the skin. Signs include red rash, itching, and blister formation. Representative examples are contact dermatitis, atopic dermatitis, and seborrheic dermatitis. [NCIT: C2983] | Trait category |
Other disease
|
Synonyms |
6 synonyms
|
Mapped terms |
7 mapped terms
|
Child trait(s) | 3 child traits |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS000738 (CONFIRMED_PGS) |
PGP000145 | Roberts GHL et al. Am J Hum Genet (2019) |
Vitiligo | Vitiligo | 48 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000738/ScoringFiles/PGS000738.txt.gz |
PGS000760 (VIT) |
PGP000164 | Khan Z et al. Nat Commun (2021) |
Vitiligo | Vitiligo | 42 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000760/ScoringFiles/PGS000760.txt.gz | |
PGS000927 (GBE_HC1158) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Other dermatitis (time-to-event) | dermatitis | 242 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000927/ScoringFiles/PGS000927.txt.gz |
PGS000944 (GBE_HC261) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Eczema, dermatitis | Eczematoid dermatitis, dermatitis |
598 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000944/ScoringFiles/PGS000944.txt.gz |
PGS001312 (GBE_HC38) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Psoriasis | psoriasis | 204 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001312/ScoringFiles/PGS001312.txt.gz |
PGS001313 (GBE_HC1159) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Psoriasis (time-to-event) | psoriasis | 578 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001313/ScoringFiles/PGS001313.txt.gz |
PGS001536 (GBE_HC1188) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Vitiligo (time-to-event) | Vitiligo | 77 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001536/ScoringFiles/PGS001536.txt.gz |
PGS001773 (PRS_atopicDermatitis) |
PGP000253 | Simard M et al. J Allergy Clin Immunol (2020) |
Moderate-to-severe atopic dermatitis | atopic eczema | 25 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001773/ScoringFiles/PGS001773.txt.gz |
PGS001871 (portability-PLR_696.4) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Psoriasis | psoriasis | 264 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001871/ScoringFiles/PGS001871.txt.gz |
PGS002083 (portability-ldpred2_696.4) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Psoriasis | psoriasis | 71,744 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002083/ScoringFiles/PGS002083.txt.gz |
PGS002293 (PRS62_psoriasis) |
PGP000323 | Shen M et al. J Am Acad Dermatol (2022) |
Psoriasis | psoriasis | 62 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002293/ScoringFiles/PGS002293.txt.gz |
PGS002344 (disease_PSORIASIS.BOLT-LMM) |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Psoriasis | psoriasis | 1,109,311 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002344/ScoringFiles/PGS002344.txt.gz |
PGS002416 (disease_PSORIASIS.P+T.0.0001) |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Psoriasis | psoriasis | 6,879 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002416/ScoringFiles/PGS002416.txt.gz |
PGS002465 (disease_PSORIASIS.P+T.0.001) |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Psoriasis | psoriasis | 21,483 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002465/ScoringFiles/PGS002465.txt.gz |
PGS002514 (disease_PSORIASIS.P+T.0.01) |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Psoriasis | psoriasis | 96,453 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002514/ScoringFiles/PGS002514.txt.gz |
PGS002563 (disease_PSORIASIS.P+T.1e-06) |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Psoriasis | psoriasis | 1,348 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002563/ScoringFiles/PGS002563.txt.gz |
PGS002612 (disease_PSORIASIS.P+T.5e-08) |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Psoriasis | psoriasis | 643 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002612/ScoringFiles/PGS002612.txt.gz |
PGS002661 (disease_PSORIASIS.PolyFun-pred) |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Psoriasis | psoriasis | 283,128 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002661/ScoringFiles/PGS002661.txt.gz |
PGS002710 (disease_PSORIASIS.SBayesR) |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Psoriasis | psoriasis | 566,839 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002710/ScoringFiles/PGS002710.txt.gz |
PGS002755 (Atopic_dermatitis_prscs) |
PGP000364 | Mars N et al. Am J Hum Genet (2022) |
Atopic dermatitis | atopic eczema | 1,090,702 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002755/ScoringFiles/PGS002755.txt.gz |
PGS003459 (PRS_CO) |
PGP000451 | Al-Janabi A et al. J Invest Dermatol (2023) |
Atopic eczema or atopic disease | atopic eczema, allergic disease |
170 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003459/ScoringFiles/PGS003459.txt.gz |
PGS003486 (PRS_AE) |
PGP000451 | Al-Janabi A et al. J Invest Dermatol (2023) |
Atopic eczema | atopic eczema | 71 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003486/ScoringFiles/PGS003486.txt.gz |
PGS004260 (GenoBoost_psoriasis_0) |
PGP000546 | Ohta R et al. Nat Commun (2024) |
Psoriasis | psoriasis | 900 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004260/ScoringFiles/PGS004260.txt.gz |
PGS004261 (GenoBoost_psoriasis_1) |
PGP000546 | Ohta R et al. Nat Commun (2024) |
Psoriasis | psoriasis | 800 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004261/ScoringFiles/PGS004261.txt.gz |
PGS004262 (GenoBoost_psoriasis_2) |
PGP000546 | Ohta R et al. Nat Commun (2024) |
Psoriasis | psoriasis | 200 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004262/ScoringFiles/PGS004262.txt.gz |
PGS004263 (GenoBoost_psoriasis_3) |
PGP000546 | Ohta R et al. Nat Commun (2024) |
Psoriasis | psoriasis | 800 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004263/ScoringFiles/PGS004263.txt.gz |
PGS004264 (GenoBoost_psoriasis_4) |
PGP000546 | Ohta R et al. Nat Commun (2024) |
Psoriasis | psoriasis | 110 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004264/ScoringFiles/PGS004264.txt.gz |
PGS004315 (GRS-ALL) |
PGP000547 | Bui A et al. Front Genet (2023) |
Psoriasis | psoriasis | 88 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004315/ScoringFiles/PGS004315.txt.gz |
PGS004316 (GRS-HLA) |
PGP000547 | Bui A et al. Front Genet (2023) |
Psoriasis | psoriasis | 11 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004316/ScoringFiles/PGS004316.txt.gz |
PGS004317 (GRS-noHLA) |
PGP000547 | Bui A et al. Front Genet (2023) |
Psoriasis | psoriasis | 77 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004317/ScoringFiles/PGS004317.txt.gz |
PGS004587 (PRS23_AD) |
PGP000566 | Gu X et al. Ecotoxicol Environ Saf (2023) |
Atopic dermatitis | atopic eczema | 23 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004587/ScoringFiles/PGS004587.txt.gz |
PGS004903 (PRS_ALL) |
PGP000633 | Al-Janabi A et al. J Allergy Clin Immunol (2023) |
Atopic dermatitis | atopic eczema | 38 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004903/ScoringFiles/PGS004903.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM001761 | PGS000738 (CONFIRMED_PGS) |
PSS000907| European Ancestry| 4,008 individuals |
PGP000145 | Roberts GHL et al. Am J Hum Genet (2019) |
Reported Trait: Vitiligo | — | — | Odds Ratio (OR, top 20% vs remaining 80% of score distribution): 4.87 [4.21, 5.64] | — | — |
PPM001762 | PGS000738 (CONFIRMED_PGS) |
PSS000907| European Ancestry| 4,008 individuals |
PGP000145 | Roberts GHL et al. Am J Hum Genet (2019) |
Reported Trait: Vitiligo | — | — | Odds Ratio (OR, top 10% vs remaining 90% of score distribution): 5.26 [4.42, 6.29] | — | — |
PPM001763 | PGS000738 (CONFIRMED_PGS) |
PSS000907| European Ancestry| 4,008 individuals |
PGP000145 | Roberts GHL et al. Am J Hum Genet (2019) |
Reported Trait: Vitiligo | — | — | Odds Ratio (OR, top 10% vs remaining 95% of score distribution): 6.2 [4.96, 7.79] | — | — |
PPM001764 | PGS000738 (CONFIRMED_PGS) |
PSS000907| European Ancestry| 4,008 individuals |
PGP000145 | Roberts GHL et al. Am J Hum Genet (2019) |
Reported Trait: Vitiligo | — | — | Odds Ratio (OR, top 1% vs remaining 99% of score distribution): 8.79 [5.85, 13.78] | — | — |
PPM018437 | PGS000738 (CONFIRMED_PGS) |
PSS010969| European Ancestry| 4,945 individuals |
PGP000467 | Farré X et al. Genes (Basel) (2023) |Ext. |
Reported Trait: Fitzpatrick scale | β: 0.02234 | — | R²: 0.02897 | — | — |
PPM018438 | PGS000738 (CONFIRMED_PGS) |
PSS010968| European Ancestry| 4,702 individuals |
PGP000467 | Farré X et al. Genes (Basel) (2023) |Ext. |
Reported Trait: Red hair | β: 0.69478 | — | pseudo R²: 0.03857 | — | — |
PPM018435 | PGS000738 (CONFIRMED_PGS) |
PSS010977| European Ancestry| 4,987 individuals |
PGP000467 | Farré X et al. Genes (Basel) (2023) |Ext. |
Reported Trait: Freckles | β: -0.04382 | — | R²: 0.02103 | — | — |
PPM018436 | PGS000738 (CONFIRMED_PGS) |
PSS010974| European Ancestry| 4,979 individuals |
PGP000467 | Farré X et al. Genes (Basel) (2023) |Ext. |
Reported Trait: Phototype score | β: 0.4039 | — | R²: 0.03252 | — | — |
PPM001935 | PGS000760 (VIT) |
PSS000970| European Ancestry| 1,584 individuals |
PGP000164 | Khan Z et al. Nat Commun (2021) |
Reported Trait: anti-PD-L1 induced hypothyroidism in cancer patients | HR: 1.41 [1.22, 1.61] | — | meta-analysis p-value: 1.10e-06 | 5 genotype PCs | — |
PPM007462 | PGS000927 (GBE_HC1158) |
PSS004153| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other dermatitis | — | AUROC: 0.61027 [0.57953, 0.64101] | R²: 0.02035 Incremental AUROC (full-covars): 0.00207 PGS R2 (no covariates): 0.00268 PGS AUROC (no covariates): 0.5378 [0.50673, 0.56886] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007463 | PGS000927 (GBE_HC1158) |
PSS004154| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other dermatitis | — | AUROC: 0.57706 [0.52927, 0.62486] | R²: 0.02951 Incremental AUROC (full-covars): 0.01147 PGS R2 (no covariates): 0.00458 PGS AUROC (no covariates): 0.5429 [0.49389, 0.59191] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007464 | PGS000927 (GBE_HC1158) |
PSS004155| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other dermatitis | — | AUROC: 0.54587 [0.53304, 0.5587] | R²: 0.00506 Incremental AUROC (full-covars): 0.01785 PGS R2 (no covariates): 0.00339 PGS AUROC (no covariates): 0.53939 [0.52639, 0.55239] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007465 | PGS000927 (GBE_HC1158) |
PSS004156| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other dermatitis | — | AUROC: 0.58261 [0.56273, 0.60248] | R²: 0.01573 Incremental AUROC (full-covars): 0.00482 PGS R2 (no covariates): 0.00187 PGS AUROC (no covariates): 0.52627 [0.50591, 0.54663] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007466 | PGS000927 (GBE_HC1158) |
PSS004157| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other dermatitis | — | AUROC: 0.56752 [0.56014, 0.57491] | R²: 0.01047 Incremental AUROC (full-covars): 0.01697 PGS R2 (no covariates): 0.00542 PGS AUROC (no covariates): 0.54889 [0.54154, 0.55624] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007546 | PGS000944 (GBE_HC261) |
PSS004384| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Eczema/dermatitis | — | AUROC: 0.62856 [0.58377, 0.67334] | R²: 0.02337 Incremental AUROC (full-covars): 0.00187 PGS R2 (no covariates): 0.00173 PGS AUROC (no covariates): 0.52778 [0.48039, 0.57516] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007547 | PGS000944 (GBE_HC261) |
PSS004385| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Eczema/dermatitis | — | AUROC: 0.59588 [0.52553, 0.66622] | R²: 0.02855 Incremental AUROC (full-covars): 0.02432 PGS R2 (no covariates): 0.0116 PGS AUROC (no covariates): 0.58664 [0.52213, 0.65115] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007548 | PGS000944 (GBE_HC261) |
PSS004386| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Eczema/dermatitis | — | AUROC: 0.56459 [0.54541, 0.58377] | R²: 0.00802 Incremental AUROC (full-covars): 0.01208 PGS R2 (no covariates): 0.00353 PGS AUROC (no covariates): 0.54597 [0.52632, 0.56561] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007549 | PGS000944 (GBE_HC261) |
PSS004387| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Eczema/dermatitis | — | AUROC: 0.56106 [0.52439, 0.59773] | R²: 0.00683 Incremental AUROC (full-covars): -0.0012 PGS R2 (no covariates): 0.00011 PGS AUROC (no covariates): 0.51686 [0.48122, 0.5525] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007550 | PGS000944 (GBE_HC261) |
PSS004388| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Eczema/dermatitis | — | AUROC: 0.57099 [0.55943, 0.58256] | R²: 0.00884 Incremental AUROC (full-covars): 0.02521 PGS R2 (no covariates): 0.00527 PGS AUROC (no covariates): 0.5556 [0.54396, 0.56724] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009053 | PGS001312 (GBE_HC38) |
PSS004471| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Psoriasis | — | AUROC: 0.73107 [0.60624, 0.85591] | R²: 0.06593 Incremental AUROC (full-covars): 0.0282 PGS R2 (no covariates): 0.01927 PGS AUROC (no covariates): 0.62557 [0.48848, 0.76266] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009054 | PGS001312 (GBE_HC38) |
PSS004472| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Psoriasis | — | AUROC: 0.88867 [0.80531, 0.97202] | R²: 0.24575 Incremental AUROC (full-covars): 0.01187 PGS R2 (no covariates): 0.00399 PGS AUROC (no covariates): 0.57774 [0.40533, 0.75016] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009055 | PGS001312 (GBE_HC38) |
PSS004473| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Psoriasis | — | AUROC: 0.68424 [0.65757, 0.71091] | R²: 0.05057 Incremental AUROC (full-covars): 0.0981 PGS R2 (no covariates): 0.04137 PGS AUROC (no covariates): 0.66409 [0.63596, 0.69222] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009056 | PGS001312 (GBE_HC38) |
PSS004474| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Psoriasis | — | AUROC: 0.6849 [0.63397, 0.73584] | R²: 0.0448 Incremental AUROC (full-covars): 0.052 PGS R2 (no covariates): 0.02087 PGS AUROC (no covariates): 0.64825 [0.59861, 0.6979] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009057 | PGS001312 (GBE_HC38) |
PSS004475| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Psoriasis | — | AUROC: 0.69754 [0.68165, 0.71343] | R²: 0.05574 Incremental AUROC (full-covars): 0.14505 PGS R2 (no covariates): 0.05226 PGS AUROC (no covariates): 0.69158 [0.6754, 0.70775] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009058 | PGS001313 (GBE_HC1159) |
PSS004158| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE psoriasis | — | AUROC: 0.69906 [0.60273, 0.7954] | R²: 0.04185 Incremental AUROC (full-covars): 0.01899 PGS R2 (no covariates): 0.00732 PGS AUROC (no covariates): 0.62223 [0.54291, 0.70154] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009059 | PGS001313 (GBE_HC1159) |
PSS004159| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE psoriasis | — | AUROC: 0.72306 [0.61623, 0.82989] | R²: 0.09162 Incremental AUROC (full-covars): 0.00222 PGS R2 (no covariates): 0.00378 PGS AUROC (no covariates): 0.48492 [0.37014, 0.5997] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009060 | PGS001313 (GBE_HC1159) |
PSS004160| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE psoriasis | — | AUROC: 0.66545 [0.64532, 0.68558] | R²: 0.04468 Incremental AUROC (full-covars): 0.07449 PGS R2 (no covariates): 0.0337 PGS AUROC (no covariates): 0.64565 [0.62471, 0.66658] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009061 | PGS001313 (GBE_HC1159) |
PSS004161| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE psoriasis | — | AUROC: 0.63418 [0.59417, 0.67419] | R²: 0.0236 Incremental AUROC (full-covars): 0.05154 PGS R2 (no covariates): 0.0123 PGS AUROC (no covariates): 0.60455 [0.56482, 0.64428] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009062 | PGS001313 (GBE_HC1159) |
PSS004162| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE psoriasis | — | AUROC: 0.67543 [0.66285, 0.68801] | R²: 0.05117 Incremental AUROC (full-covars): 0.13853 PGS R2 (no covariates): 0.04966 PGS AUROC (no covariates): 0.6729 [0.66027, 0.68553] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005215 | PGS001536 (GBE_HC1188) |
PSS004173| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE vitiligo | — | AUROC: 0.63509 [0.52563, 0.74454] | R²: 0.01654 Incremental AUROC (full-covars): -0.00281 PGS R2 (no covariates): 0.0 PGS AUROC (no covariates): 0.51169 [0.39527, 0.62811] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005216 | PGS001536 (GBE_HC1188) |
PSS004174| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE vitiligo | — | AUROC: 0.82774 [0.75298, 0.90249] | R²: 0.08055 Incremental AUROC (full-covars): 0.01924 PGS R2 (no covariates): 0.00431 PGS AUROC (no covariates): 0.57823 [0.37976, 0.7767] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005217 | PGS001536 (GBE_HC1188) |
PSS004175| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE vitiligo | — | AUROC: 0.6991 [0.61917, 0.77902] | R²: 0.03993 Incremental AUROC (full-covars): 0.01341 PGS R2 (no covariates): 0.00254 PGS AUROC (no covariates): 0.55625 [0.47549, 0.63701] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005218 | PGS001536 (GBE_HC1188) |
PSS004176| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE vitiligo | — | AUROC: 0.64566 [0.58746, 0.70386] | R²: 0.02575 Incremental AUROC (full-covars): 0.0309 PGS R2 (no covariates): 0.01048 PGS AUROC (no covariates): 0.60302 [0.5391, 0.66694] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005219 | PGS001536 (GBE_HC1188) |
PSS004177| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE vitiligo | — | AUROC: 0.63449 [0.58754, 0.68144] | R²: 0.01686 Incremental AUROC (full-covars): 0.08163 PGS R2 (no covariates): 0.01621 PGS AUROC (no covariates): 0.64193 [0.59907, 0.68478] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009229 | PGS001773 (PRS_atopicDermatitis) |
PSS007661| Multi-ancestry (including European)| 676 individuals |
PGP000253 | Simard M et al. J Allergy Clin Immunol (2020) |
Reported Trait: Moderate-to-severe aotpic dermatitis | — | AUROC: 0.93 | R²: 0.49 | Age, sex, father's ethnicity, mother ethnicity | Nagelkerke's R^2, only unrelated individuals were considered in the analyses |
PPM009230 | PGS001773 (PRS_atopicDermatitis) |
PSS007661| Multi-ancestry (including European)| 676 individuals |
PGP000253 | Simard M et al. J Allergy Clin Immunol (2020) |
Reported Trait: Food allergy | — | AUROC: 0.75 | — | Age, sex, father's ethnicity, mother ethnicity | Only unrelated individuals were considered in the analyses |
PPM009231 | PGS001773 (PRS_atopicDermatitis) |
PSS007661| Multi-ancestry (including European)| 676 individuals |
PGP000253 | Simard M et al. J Allergy Clin Immunol (2020) |
Reported Trait: Allergic asthma | — | AUROC: 0.75 | — | Age, sex, father's ethnicity, mother ethnicity | Only unrelated individuals were considered in the analyses |
PPM009232 | PGS001773 (PRS_atopicDermatitis) |
PSS007661| Multi-ancestry (including European)| 676 individuals |
PGP000253 | Simard M et al. J Allergy Clin Immunol (2020) |
Reported Trait: Allergic rhinitis | — | AUROC: 0.77 | — | Age, sex, father's ethnicity, mother ethnicity | Only unrelated individuals were considered in the analyses |
PPM009857 | PGS001871 (portability-PLR_696.4) |
PSS009347| European Ancestry| 19,615 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.0636 [0.0497, 0.0775] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009858 | PGS001871 (portability-PLR_696.4) |
PSS009121| European Ancestry| 4,059 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.107 [0.0764, 0.1374] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009859 | PGS001871 (portability-PLR_696.4) |
PSS008675| European Ancestry| 6,554 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.0404 [0.0162, 0.0646] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009860 | PGS001871 (portability-PLR_696.4) |
PSS008449| Greater Middle Eastern Ancestry| 1,183 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.0463 [-0.0112, 0.1035] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009861 | PGS001871 (portability-PLR_696.4) |
PSS008229| South Asian Ancestry| 6,161 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.0327 [0.0077, 0.0577] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009862 | PGS001871 (portability-PLR_696.4) |
PSS008010| East Asian Ancestry| 1,784 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.0079 [-0.0388, 0.0545] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009863 | PGS001871 (portability-PLR_696.4) |
PSS007794| African Ancestry| 2,398 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.0357 [-0.0045, 0.0757] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009864 | PGS001871 (portability-PLR_696.4) |
PSS008898| African Ancestry| 3,834 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): -0.0065 [-0.0382, 0.0252] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011525 | PGS002083 (portability-ldpred2_696.4) |
PSS009347| European Ancestry| 19,615 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.0632 [0.0493, 0.0771] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011526 | PGS002083 (portability-ldpred2_696.4) |
PSS009121| European Ancestry| 4,059 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.1153 [0.0847, 0.1456] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011527 | PGS002083 (portability-ldpred2_696.4) |
PSS008675| European Ancestry| 6,554 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.041 [0.0168, 0.0652] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011529 | PGS002083 (portability-ldpred2_696.4) |
PSS008229| South Asian Ancestry| 6,161 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.03 [0.005, 0.055] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011530 | PGS002083 (portability-ldpred2_696.4) |
PSS008010| East Asian Ancestry| 1,784 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.0119 [-0.0348, 0.0585] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011531 | PGS002083 (portability-ldpred2_696.4) |
PSS007794| African Ancestry| 2,398 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.0375 [-0.0027, 0.0776] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011532 | PGS002083 (portability-ldpred2_696.4) |
PSS008898| African Ancestry| 3,834 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): -0.0166 [-0.0483, 0.0152] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011528 | PGS002083 (portability-ldpred2_696.4) |
PSS008449| Greater Middle Eastern Ancestry| 1,183 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Psoriasis | — | — | Partial Correlation (partial-r): 0.0458 [-0.0117, 0.1031] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM013020 | PGS002293 (PRS62_psoriasis) |
PSS009651| European Ancestry| 345,672 individuals |
PGP000323 | Shen M et al. J Am Acad Dermatol (2022) |
Reported Trait: Incident psoriasis | HR: 4.625 [2.92, 7.348] | — | Odds Ratio (OR, poor lifestyle and high genetic risk): 4.625 [2.92, 7.348] Population-attributable fraction of genetic risk: 0.13 [0.032, 0.218] |
Age, sex, education, Townsend Index, and region, relatedness, number of alleles included in the polygenic risk score, and first 20 principal components of ancestry | — |
PPM013109 | PGS002344 (disease_PSORIASIS.BOLT-LMM) |
PSS009819| African Ancestry| 6,503 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0001 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013158 | PGS002344 (disease_PSORIASIS.BOLT-LMM) |
PSS009820| East Asian Ancestry| 922 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.001 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013207 | PGS002344 (disease_PSORIASIS.BOLT-LMM) |
PSS009821| European Ancestry| 43,505 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.007 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013256 | PGS002344 (disease_PSORIASIS.BOLT-LMM) |
PSS009822| South Asian Ancestry| 8,098 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0035 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013397 | PGS002416 (disease_PSORIASIS.P+T.0.0001) |
PSS009819| African Ancestry| 6,503 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0005 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013446 | PGS002416 (disease_PSORIASIS.P+T.0.0001) |
PSS009820| East Asian Ancestry| 922 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0002 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013495 | PGS002416 (disease_PSORIASIS.P+T.0.0001) |
PSS009821| European Ancestry| 43,505 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013544 | PGS002416 (disease_PSORIASIS.P+T.0.0001) |
PSS009822| South Asian Ancestry| 8,098 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013593 | PGS002465 (disease_PSORIASIS.P+T.0.001) |
PSS009819| African Ancestry| 6,503 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0003 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013642 | PGS002465 (disease_PSORIASIS.P+T.0.001) |
PSS009820| East Asian Ancestry| 922 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0002 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013691 | PGS002465 (disease_PSORIASIS.P+T.0.001) |
PSS009821| European Ancestry| 43,505 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013740 | PGS002465 (disease_PSORIASIS.P+T.0.001) |
PSS009822| South Asian Ancestry| 8,098 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0001 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013789 | PGS002514 (disease_PSORIASIS.P+T.0.01) |
PSS009819| African Ancestry| 6,503 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0003 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013838 | PGS002514 (disease_PSORIASIS.P+T.0.01) |
PSS009820| East Asian Ancestry| 922 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0001 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013887 | PGS002514 (disease_PSORIASIS.P+T.0.01) |
PSS009821| European Ancestry| 43,505 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013936 | PGS002514 (disease_PSORIASIS.P+T.0.01) |
PSS009822| South Asian Ancestry| 8,098 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM013985 | PGS002563 (disease_PSORIASIS.P+T.1e-06) |
PSS009819| African Ancestry| 6,503 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0004 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM014034 | PGS002563 (disease_PSORIASIS.P+T.1e-06) |
PSS009820| East Asian Ancestry| 922 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0001 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM014083 | PGS002563 (disease_PSORIASIS.P+T.1e-06) |
PSS009821| European Ancestry| 43,505 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM014132 | PGS002563 (disease_PSORIASIS.P+T.1e-06) |
PSS009822| South Asian Ancestry| 8,098 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM014181 | PGS002612 (disease_PSORIASIS.P+T.5e-08) |
PSS009819| African Ancestry| 6,503 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0007 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM014230 | PGS002612 (disease_PSORIASIS.P+T.5e-08) |
PSS009820| East Asian Ancestry| 922 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0001 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM014279 | PGS002612 (disease_PSORIASIS.P+T.5e-08) |
PSS009821| European Ancestry| 43,505 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM014328 | PGS002612 (disease_PSORIASIS.P+T.5e-08) |
PSS009822| South Asian Ancestry| 8,098 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM014377 | PGS002661 (disease_PSORIASIS.PolyFun-pred) |
PSS009819| African Ancestry| 6,503 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model when combined with BOLT-LMM vs. covariates alone): 0.0001 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | See disease_PSORIASIS.mixweights file at http://data.broadinstitute.org/alkesgroup/polypred_results for combination weights |
PPM014426 | PGS002661 (disease_PSORIASIS.PolyFun-pred) |
PSS009820| East Asian Ancestry| 922 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model when combined with BOLT-LMM vs. covariates alone): 0.0 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | See disease_PSORIASIS.mixweights file at http://data.broadinstitute.org/alkesgroup/polypred_results for combination weights |
PPM014475 | PGS002661 (disease_PSORIASIS.PolyFun-pred) |
PSS009821| European Ancestry| 43,505 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model when combined with BOLT-LMM vs. covariates alone): 0.007 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | See disease_PSORIASIS.mixweights file at http://data.broadinstitute.org/alkesgroup/polypred_results for combination weights |
PPM014524 | PGS002661 (disease_PSORIASIS.PolyFun-pred) |
PSS009822| South Asian Ancestry| 8,098 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model when combined with BOLT-LMM vs. covariates alone): 0.0034 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | See disease_PSORIASIS.mixweights file at http://data.broadinstitute.org/alkesgroup/polypred_results for combination weights |
PPM014622 | PGS002710 (disease_PSORIASIS.SBayesR) |
PSS009820| East Asian Ancestry| 922 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0002 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM014671 | PGS002710 (disease_PSORIASIS.SBayesR) |
PSS009821| European Ancestry| 43,505 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0014 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM014720 | PGS002710 (disease_PSORIASIS.SBayesR) |
PSS009822| South Asian Ancestry| 8,098 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.002 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM014573 | PGS002710 (disease_PSORIASIS.SBayesR) |
PSS009819| African Ancestry| 6,503 individuals |
PGP000332 | Weissbrod O et al. Nat Genet (2022) |
Reported Trait: Psoriasis | — | — | Incremental R2 (full model vs. covariates alone): 0.0001 | age, sex, age*sex, assessment center, genotyping array, 10 PCs | — |
PPM014955 | PGS002755 (Atopic_dermatitis_prscs) |
PSS009939| European Ancestry| 39,444 individuals |
PGP000364 | Mars N et al. Am J Hum Genet (2022) |
Reported Trait: Atopic dermatitis | OR: 1.28 [1.21, 1.34] | — | — | age, sex, 10 PCs, technical covariates | — |
PPM020709 | PGS002755 (Atopic_dermatitis_prscs) |
PSS011376| European Ancestry| 337,910 individuals |
PGP000566 | Gu X et al. Ecotoxicol Environ Saf (2023) |Ext. |
Reported Trait: Incident atopic dermatitis | — | — | Hazard ratio (HR, high vs low PRS): 1.249 [1.123, 1.391] | sex, age, Townsend index, moderate physical and household income | — |
PPM020710 | PGS002755 (Atopic_dermatitis_prscs) |
PSS011376| European Ancestry| 337,910 individuals |
PGP000566 | Gu X et al. Ecotoxicol Environ Saf (2023) |Ext. |
Reported Trait: Incident atopic dermatitis with air pollution level | — | — | Hazard ratio (HR, high air pollution and high PRS vs low air pollution and low PRS): 1.978 [1.624, 2.411] | sex, age, Townsend index, moderate physical and household income | — |
PPM017414 | PGS003459 (PRS_CO) |
PSS010186| European Ancestry| 3,212 individuals |
PGP000451 | Al-Janabi A et al. J Invest Dermatol (2023) |
Reported Trait: Paradoxical eczema in biologic-treated psoriasis | OR: 1.83 [1.17, 2.84] | AUROC: 0.585 | — | PCs 1-2 | — |
PPM017412 | PGS003486 (PRS_AE) |
PSS010186| European Ancestry| 3,212 individuals |
PGP000451 | Al-Janabi A et al. J Invest Dermatol (2023) |
Reported Trait: Paradoxical eczema in biologic-treated psoriasis | OR: 1.89 [1.08, 3.3] | AUROC: 0.567 | — | PCs 1-2 | — |
PPM020328 | PGS004260 (GenoBoost_psoriasis_0) |
PSS011347| European Ancestry| 67,428 individuals |
PGP000546 | Ohta R et al. Nat Commun (2024) |
Reported Trait: Psoriasis | — | AUROC: 0.66908 | Covariate-adjusted pseudo-R2: 0.04239 AUPRC: 0.04468 |
age, sex, PC1-10 | — |
PPM020329 | PGS004261 (GenoBoost_psoriasis_1) |
PSS011347| European Ancestry| 67,428 individuals |
PGP000546 | Ohta R et al. Nat Commun (2024) |
Reported Trait: Psoriasis | — | AUROC: 0.67722 | Covariate-adjusted pseudo-R2: 0.04563 AUPRC: 0.0457 |
age, sex, PC1-10 | — |
PPM020330 | PGS004262 (GenoBoost_psoriasis_2) |
PSS011347| European Ancestry| 67,428 individuals |
PGP000546 | Ohta R et al. Nat Commun (2024) |
Reported Trait: Psoriasis | — | AUROC: 0.66916 | Covariate-adjusted pseudo-R2: 0.04211 AUPRC: 0.0431 |
age, sex, PC1-10 | — |
PPM020331 | PGS004263 (GenoBoost_psoriasis_3) |
PSS011347| European Ancestry| 67,428 individuals |
PGP000546 | Ohta R et al. Nat Commun (2024) |
Reported Trait: Psoriasis | — | AUROC: 0.67205 | Covariate-adjusted pseudo-R2: 0.04423 AUPRC: 0.04681 |
age, sex, PC1-10 | — |
PPM020332 | PGS004264 (GenoBoost_psoriasis_4) |
PSS011347| European Ancestry| 67,428 individuals |
PGP000546 | Ohta R et al. Nat Commun (2024) |
Reported Trait: Psoriasis | — | AUROC: 0.66842 | Covariate-adjusted pseudo-R2: 0.04356 AUPRC: 0.04551 |
age, sex, PC1-10 | — |
PPM020383 | PGS004315 (GRS-ALL) |
PSS011349| European Ancestry| 654 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Family history of psoriasis | OR: 1.02 [1.0, 1.04] | — | R²: 0.0067 | — | — |
PPM020384 | PGS004315 (GRS-ALL) |
PSS011349| European Ancestry| 654 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Age of psoriasis onset | OR: 0.71 [0.59, 0.85] | — | R²: 0.023 | — | — |
PPM020386 | PGS004315 (GRS-ALL) |
PSS011349| European Ancestry| 654 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Age of type1 psoriasis onset | OR: 0.82 [0.59, 0.85] | — | R²: 0.0206 | — | — |
PPM020388 | PGS004315 (GRS-ALL) |
PSS011349| European Ancestry| 654 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Psoriasis severity | OR: 1.02 [1.0, 1.06] | — | R²: 0.061 | — | — |
PPM020390 | PGS004315 (GRS-ALL) |
PSS011349| European Ancestry| 654 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Total number of locations ever affected by psoriasis | OR: 1.16 [1.11, 1.21] | — | R²: 0.061 | — | — |
PPM020393 | PGS004315 (GRS-ALL) |
PSS011349| European Ancestry| 654 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Initial presentation of psoriasis at elbow or knee | OR: 0.97 [0.94, 0.99] | — | — | — | — |
PPM020396 | PGS004315 (GRS-ALL) |
PSS011348| European Ancestry| 345 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Psoriasis in genital area | β: -0.037 (0.016) | — | — | — | — |
PPM020385 | PGS004316 (GRS-HLA) |
PSS011349| European Ancestry| 654 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Age of psoriasis onset | OR: 0.46 [0.34, 0.63] | — | R²: 0.0398 | — | — |
PPM020387 | PGS004316 (GRS-HLA) |
PSS011349| European Ancestry| 654 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Age of type1 psoriasis onset | OR: 0.69 [0.56, 0.86] | — | R²: 0.0216 | — | — |
PPM020389 | PGS004316 (GRS-HLA) |
PSS011349| European Ancestry| 654 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Psoriasis severity | OR: 1.09 [1.03, 1.15] | — | R²: 0.077 | — | — |
PPM020391 | PGS004316 (GRS-HLA) |
PSS011349| European Ancestry| 654 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Total number of locations ever affected by psoriasis | OR: 1.34 [1.24, 1.45] | — | R²: 0.077 | — | — |
PPM020394 | PGS004316 (GRS-HLA) |
PSS011349| European Ancestry| 654 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Initial presentation of psoriasis at elbow or knee | OR: 0.92 [0.88, 0.96] | — | — | — | — |
PPM020392 | PGS004317 (GRS-noHLA) |
PSS011349| European Ancestry| 654 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Psoriasis in genital area | OR: 0.97 [0.94, 1.0] | — | — | — | — |
PPM020395 | PGS004317 (GRS-noHLA) |
PSS011348| European Ancestry| 345 individuals |
PGP000547 | Bui A et al. Front Genet (2023) |
Reported Trait: Psoriasis in genital area | β: -0.038 (0.019) | — | — | — | — |
PPM020707 | PGS004587 (PRS23_AD) |
PSS011376| European Ancestry| 337,910 individuals |
PGP000566 | Gu X et al. Ecotoxicol Environ Saf (2023) |
Reported Trait: Incident atopic dermatitis | — | — | Hazard ratio (HR, high vs low PRS): 1.153 [1.037, 1.282] | sex, age, Townsend index, moderate physical and household income | — |
PPM020708 | PGS004587 (PRS23_AD) |
PSS011376| European Ancestry| 337,910 individuals |
PGP000566 | Gu X et al. Ecotoxicol Environ Saf (2023) |
Reported Trait: Incident atopic dermatitis with air pollution level | — | — | Hazard ratio (HR, high air pollution and high PRS vs low air pollution and low PRS): 1.523 [1.259, 1.84] | sex, age, Townsend index, moderate physical and household income | — |
PPM021335 | PGS004903 (PRS_ALL) |
PSS011691| European Ancestry| 3,212 individuals |
PGP000633 | Al-Janabi A et al. J Allergy Clin Immunol (2023) |
Reported Trait: Paradoxical eczema in individuals with psoriasis | — | — | Coefficient: 4.77 [0.58, 8.96] p: 0.026 |
— | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS004156 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004157 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004158 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004159 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004160 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004161 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004162 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS008010 | — | — | 1,784 individuals | — | East Asian | China (East Asia) | UKB | — |
PSS011691 | — | — | [
|
— | European | — | BSTOP | — |
PSS004173 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004174 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004175 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004176 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004177 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS000907 | Cases are individuals with vitiligo. Diagnoses of vitiligo in multiplex-affected subjects and reportedly unaffected family members were verified by manual review of all available phenotype information for each subject. | — | [
|
— | European | — | NR | — |
PSS008675 | — | — | 6,554 individuals | — | European | Italy (South Europe) | UKB | — |
PSS007794 | — | — | 2,398 individuals | — | African American or Afro-Caribbean | Carribean | UKB | — |
PSS008898 | — | — | 3,834 individuals | — | African unspecified | Nigeria (West Africa) | UKB | — |
PSS007661 | For the CHILD Cohort Study, atopic dermatitis (AD) was from physician diagnosis at the one year follow-up. AD severity was defined as mild if there is a single site or no more than 2 sites, minor symptoms (little itching/rubbing), minor crusting and papules, not excoriated or oozing, not needing frequent medical attention; was defined as moderate if symptoms are neither mild nor severe or; was defined as severe if there are multiple sites, with extensive crusting or papules or excoriations or oozing or lichenification, sleep loss, needing frequent medical attention, and is a major concern to parents. In the SLSJ Cohort, atopic dermatitis was self-reported and considered as positive if past or present occurrence was reported. For children, cross validation was done using questionnaires filled by their parents. Moreover, validation in medical records of these self-reported phenotypes were done for a subset of the SLSJ Cohort (n = 217), giving 89% concordance. | — | [ ,
42.0 % Male samples |
Mean = 9.0 years Range = [0.0, 87.0] years |
European, South East Asian, East Asian, South Asian, African American or Afro-Caribbean, Native American, Greater Middle Eastern (Middle Eastern, North African or Persian), Hispanic or Latin American, Not reported | — | CHILD, SLSJ | Also used to evaluate the PRS_atopicDermatitis for other diseases of the atopic march: food allergy, allergic asthma and rhinitis. Only unrelated individuals were selected for analyses. |
PSS011347 | — | — | [ ,
46.0 % Male samples |
— | European (White British) |
— | UKB | — |
PSS011348 | — | — | 345 individuals, 52.0 % Male samples |
Mean = 49.0 years Sd = 16.0 years |
European | — | UCSF | — |
PSS011349 | — | — | 654 individuals, 48.0 % Male samples |
Mean = 41.0 years Sd = 14.0 years |
European | — | NR | — |
PSS004471 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004472 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004473 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004474 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004475 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS009347 | — | — | 19,615 individuals | — | European | UK (+ Ireland) | UKB | — |
PSS008449 | — | — | 1,183 individuals | — | Greater Middle Eastern (Middle Eastern, North African or Persian) | Iran (Middle East) | UKB | — |
PSS000970 | — | Median = 400.0 days | 1,584 individuals | — | European | — | GNEHGI2020Q2 | — |
PSS009651 | — | Median = 10.88 years | 345,672 individuals, 48.0 % Male samples |
Mean = 56.53 years Sd = 8.06 years |
European | — | UKB | — |
PSS009819 | — | — | 6,503 individuals | — | African unspecified | — | UKB | — |
PSS009820 | — | — | 922 individuals | — | East Asian | — | UKB | — |
PSS009821 | — | — | 43,505 individuals | — | European | Non-British European | UKB | — |
PSS009822 | — | — | 8,098 individuals | — | South Asian | — | UKB | — |
PSS010186 | Plaque psoriasis patients with at least one exposure to biologic therapy. Cases developed one or more paradoxical eczema adverse events during treatment with one of the following biologics: TNF-alpha inhibitors (adalimumab; etanercept; certolizumab; infliximab), IL-17 inhibitors (brodalumab; secukinumab; ixekizumab), IL-12/23 inhibitors (ustekinumab) and IL-23p19 inhibitors (guselkumab; risankizumab; tildrakizumab). Controls has no recorded eczema events during biologic therapy. Participants may have been exposed to more than one biologic. | — | [
|
— | European | — | BSTOP | — |
PSS010968 | — | — | [
|
— | European | — | NR | GCAT |
PSS010969 | — | — | [
|
— | European | — | NR | GCAT |
PSS009121 | — | — | 4,059 individuals | — | European | Poland (NE Europe) | UKB | — |
PSS009939 | — | — | 39,444 individuals | — | European (Finnish) |
— | FinnGen | — |
PSS008229 | — | — | 6,161 individuals | — | South Asian | India (South Asia) | UKB | — |
PSS010974 | — | — | [
|
— | European | — | NR | GCAT |
PSS004384 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004385 | — | — | [
|
— | East Asian | — | UKB | — |
PSS010977 | — | — | 4,987 individuals | — | European | — | NR | GCAT |
PSS004386 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004387 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004388 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS011376 | — | Median = 12.0 years | 337,910 individuals, 45.6 % Male samples |
Mean = 57.1 years Sd = 8.0 years |
European | — | UKB | — |
PSS004153 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004154 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004155 | — | — | [
|
— | European | non-white British ancestry | UKB | — |